*Naomi Hasegawa¹, Hisashi Yamada², Hikaru Hori³, Norio Yasui-Furukori⁴, Junya Matsumoto¹, Kenichiro Miura¹, Ken Inada⁵, Koichiro Watanabe⁶, Ryota Hashimoto¹ (1. Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, 2. 4.Department of Neuropsychiatry, Hyogo Medical University, Hyogo, 3. 5.Department of Psychiatry, Faculty of Medicine, Fukuoka University, 4. 3.Department of Psychiatry, Dokkyo Medical University School of Medicine, 5. 9.Department of Psychiatry, Kitasato University, School of Medicine, 6. 17.Department of Neuropsychiatry, Kyorin University School of Medicine)

*Masahiro Takeshima¹, Akise Umakoshi¹, Yoshizawa Kazuhisa¹, Masaya Ogasawara¹, Yu Itoh¹, Kazuo Mishima¹ (1. Department of Neuropsychiatry, Akita University Graduate School of Medicine)

*Minoru Urata¹, Fumihiko Ueno², Takahito Uchida^3,4, Yasuyuki Matsumoto¹, Masami Murao¹, Taku Maruki¹, Masayuki Tomita⁵, Takashi Tsuboi¹, Koichiro Watanabe¹, Hitoshi Sakurai¹ (1. Department of Neuropsychiatry, Kyorin University Faculty of Medicine, 2. Brain Health Imaging Centre, Centre for Addiction and Mental Health, 3. Uchida clinic, 4. Department of Neuropsychiatry, Keio University School of Medicine, 5. Oizumi hospital)

*Masahide Karashima¹, hitomi ueki¹, kazuhiro onuma¹, makoto hiraide², takahiro terunuma¹, takahumi hori³ (1. Ibaraki Prefectural Medical Center of Psychiatry,Pharmacy Division, 2. School of Pharmacy and Pharmaceutical Sciences,Hoshi University, 3. Ibaraki Prefectural Medical Center of Psychiatry)

*Chika Nakayama¹, Yukina Miyagi^2,3, Saori Gocho^2,3,4, Yuka Miyachi², Taeyuki Oshima² (1. Faculty of Pharmacy, Gifu University of Medical Science, 2. College of Pharmacy, Kinjo Gakuin University, 3. Graduate School of Medicine, Aichi Medical University, 4. Department of Pharmacy, Nagoya Ekisaikai Hospital)

*Yosuke Koshikawa¹, Chikashi Takano^1,2, Toshiya Funatsuki¹, Yuji Murase¹, Hiroki Bando³, Minami Minami¹, Haruhiko Ogata¹, Yutaro Shimamoto⁴, Atsuko Yamamoto¹, Shoko Takano¹, Toshihiko Kinoshita¹, Masaki Kato¹, Yoshiteru Takekita¹ (1. Department of Neuropsychiatry. Kansai Medical University, 2. Kobe Shirasagi Hospital Group, 3. Sephiroth Hospital, 4. Setagawa Hospital)

*Hirotaka Tominaga¹, Taro Suwa², Toshiyuki Shimizu³, Nobuatsu Aoki^3,4,5, Kazuyuki Yasuda⁶, Niina Utinuma⁶, Aran Tajika⁷, Yoshiteru Takekita³ (1. Showakai Mojimatsugae Hospital, 2. Department of Psychiatry, Graduate School of Medicine, Kyoto University, 3. Department of Neuropsychiatry, Kansai Medical University, 4. Psychiatry and Mental Health, University of New South Wales, 5. Black Dog Institute, Sydney, 6. Department of Neuropsychiatry, University of Yamanashi Faculty of Medicine., 7. Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine / School of Public Health)